Sofinnova

Company — aTyr Pharma

October 24, 2017

Focused on the discovery and clinical development of innovative medicines for patients suffering from severe rare diseases using its knowledge of Physiocrine biology, a newly discovered set of physiological modulators. (NASDAQ: LIFE)